• American Cancer Society's "New Year, Choose You" Sweepstakes

    Updated: 2010-12-29 21:45:00
    , About Us Sponsored : by CTCA Cancer News Deadliest Cancer Getting Smaller Chunk of Research Dollars Lung cancer spending should focus more on detection and treatment , advocates say Read full story Cancer News Categories Breast Cancer News Colorectal Cancer News Gynecologic Cancer News Hematological Cancer News Lung Cancer News Prostate Cancer News Pancreatic Cancer News Other Cancer News Message Board Cancers Bladder Cancer Bone Cancer Brain Cancer Breast Cancer Colon Cancer Esophageal Cancer Gynecological Cancers Kidney Cancer Leukemia Liver Cancer Lung Cancer Melanoma Pancreatic Cancer Prostate Cancer Stomach Cancer Testicular Cancer After Treatment Emotional Support Nutritional Concerns Side Effects Cancer Diagnosis Diagnostic Imaging Lab Tests Other Tests Cancer Nutrition Diet

  • Understanding Castrate Resistant Prostate Cancer (CRPC)

    Updated: 2010-12-29 19:15:30
    There is a brief, but great YouTube video that very simply and clearly explains the current thinking about how and why prostate cancer becomes androgen independent (castrate resistant). View the video by clicking here Joel T Nowak, M.A., M.S.W.

  • Cervical Cancer Awareness Month Begins This Week

    Updated: 2010-12-29 06:11:00
    About Us Sponsored : by CTCA Cancer News Zen Meditation Can Help Bring Pain Under Control Doesn't eliminate feeling , but reduces thoughts about pain Read full story Cancer News Categories Breast Cancer News Colorectal Cancer News Gynecologic Cancer News Hematological Cancer News Lung Cancer News Prostate Cancer News Pancreatic Cancer News Other Cancer News Message Board Cancers Bladder Cancer Bone Cancer Brain Cancer Breast Cancer Colon Cancer Esophageal Cancer Gynecological Cancers Kidney Cancer Leukemia Liver Cancer Lung Cancer Melanoma Pancreatic Cancer Prostate Cancer Stomach Cancer Testicular Cancer After Treatment Emotional Support Nutritional Concerns Side Effects Cancer Diagnosis Diagnostic Imaging Lab Tests Other Tests Cancer Nutrition Diet Recipes Supplements Cancer Prevention

  • Zoledronic Acid Therapy Impacts Risk and Frequency of Skeletal Complications In Men with Prostate Cancer – Start Early Therapy

    Updated: 2010-12-28 16:32:31
    To evaluate the effects of timing and length of zoledronic acid (ZA) treatment on outcomes for men with prostate cancer, researchers from the University of Illinois at Chicago and the Hind T. Hatoum & Company, Chicago, IL. evaluated a large contingent of men who had been diagnosed with prostate cancer from January 2003 to October [...]

  • A leading health policy issue for 2010-11: communicating tradeoffs in screening test decisions

    Updated: 2010-12-28 16:12:39
    : Gary Schwitzer's HealthNewsReview Blog Gary Schwitzer Publisher , HealthNewsReview.org feedback healthnewsreview.org A leading health policy issue for 2010-11 : communicating tradeoffs in screening test decisions By Gary Schwitzer on December 28, 2010 10:12 AM No Comments No TrackBacks One trend that stands out from 2010 is what I call screening madness . I'm referring specifically and solely to the promotion of screening tests outside the boundaries of evidence and to the emphasis only on the benefits of screening tests with concomitant downplaying or complete disregard for the harms of screening . Why is this a health policy issue There are several obvious reasons . If we don't communicate balanced information on harms as well as benefits of screening tests , we're probably never going

  • Age No Barrier to Prostate Cancer Tx

    Updated: 2010-12-28 14:00:00
    Decisions about prostate cancer treatment may rely too heavily on age, research suggests.

  • Kent Bottles: The Difficult Science Behind Becoming a Savvy Healthcare Consumer

    Updated: 2010-12-27 21:22:30
    : Gary Schwitzer's HealthNewsReview Blog Gary Schwitzer Publisher , HealthNewsReview.org feedback healthnewsreview.org Kent Bottles : The Difficult Science Behind Becoming a Savvy Healthcare Consumer By Gary Schwitzer on December 27, 2010 3:22 PM No Comments No TrackBacks Dr . Kent Bottles is in the midst of a very thoughtful multi-part blog post under the heading , The Difficult Science Behind Becoming a Savvy Healthcare Consumer . Part I examined the limitations of science in helping us make wise choices and decisions about our health . Part II explores how we all have to change if we are to live wisely in a time of rapid transformation of the American healthcare system that everyone agrees needs to decrease per-capita cost and increase quality . Both parts so far have addressed

  • Disease and Host Characteristics as Predictors of Time to First Bone Metastasis and Death in Men with Castration Resistant Nonmetastatic Prostate Cancer

    Updated: 2010-12-27 15:23:00
    Researchers at the Department of Hematology-Oncology, Massachusetts General Hospital Cancer Center, Boston, Massachusetts performed an evaluation of the natural history of castration-resistant non-metastatic prostate cancer. For their analysis, the researchers used data from 331 subjects in a placebo group of a randomized controlled trial to evaluate the relations of disease and host characteristics with time [...]

  • Projecting the Years of Potential Life Lost from Advanced Prostate Cancer in the U.S. (2004-2050)

    Updated: 2010-12-23 16:35:47
    This study estimated and projected the number of years of potential life lost (YPLL) among men who die of prostate cancer(advanced prostate cancer) in the United States from 2004 through 2050 and compare the projections by race/ethnicity and age, accounting for demographic changes and population growth. The researchers applied the life expectancy method to estimate [...]

  • Study: Tanning Beds Still Draw a Crowd

    Updated: 2010-12-23 15:23:00
    : About Us Sponsored : by CTCA Cancer News Zen Meditation Can Help Bring Pain Under Control Doesn't eliminate feeling , but reduces thoughts about pain Read full story Cancer News Categories Breast Cancer News Colorectal Cancer News Gynecologic Cancer News Hematological Cancer News Lung Cancer News Prostate Cancer News Pancreatic Cancer News Other Cancer News Message Board Cancers Bladder Cancer Bone Cancer Brain Cancer Breast Cancer Colon Cancer Esophageal Cancer Gynecological Cancers Kidney Cancer Leukemia Liver Cancer Lung Cancer Melanoma Pancreatic Cancer Prostate Cancer Stomach Cancer Testicular Cancer After Treatment Emotional Support Nutritional Concerns Side Effects Cancer Diagnosis Diagnostic Imaging Lab Tests Other Tests Cancer Nutrition Diet Recipes Supplements Cancer Prevention

  • UK survival for major cancers improves, but still lags behind other countries

    Updated: 2010-12-22 11:50:00
    Despite gaining ground, survival rates for newly diagnosed breast, ovarian, bowel and lung cancers were still lower in the UK than in Australia, Canada and Sweden between 1995 and 2007, a new study in the Lancet medical journal shows.

  • Risk comm guru Gigerenzer argues that absolute risk communication is a moral issue

    Updated: 2010-12-21 16:09:59
    Gary Schwitzer's HealthNewsReview Blog Gary Schwitzer Publisher , HealthNewsReview.org feedback healthnewsreview.org Risk comm guru Gigerenzer argues that absolute risk communication is a moral issue By Gary Schwitzer on December 21, 2010 10:09 AM No Comments No TrackBacks Professor Gerd Gigerenzer of the Max Planck Institute for Human Development in Berlin is one of the world's leaders in risk communication . He teaches doctors , policy-makers , journalists and the general public . He has written before about how misleading communication of risk is a moral issue for medical journals , for journalists , for researchers , and for anyone who communicates to the public about health care issues . For example , see his October editorial in the BMJ . Excerpt : In 1995, the UK Committee on Safety

  • An Update on the FDA & EMA Submissions for Abiraterone for the Treatment of Metastatic Advanced Prostate Cancer

    Updated: 2010-12-21 15:51:08
    Applications for the approval of Abiraterone Acetate (Abiraterone) have been submitted to both the U.S. Food and Drug Administration (FDA) and to the European Medicines Agency (EMA). The applications are for the approval of Abiraterone with prednisone for the treatment of metastatic advanced prostate cancer in men who have received prior chemotherapy containing a taxane. [...]

  • Latest in ProPublica's Dollars for Docs project - What Drug Companies are Paying Your Doctor

    Updated: 2010-12-20 21:58:28
    See: Med Schools Flunk at Keeping Faculty Off Pharma Speaking Circuit and Drug Companies Retain Tight Control of Physicians' Presentations

  • Stage IV Prostate Cancer Incidence Down, Survival Up, But More Younger Men Make up an Increased Proportion of the Diagnosed

    Updated: 2010-12-20 19:17:11
    According to a study funded by Amgen Inc., the incidence of stage IV prostate cancer has significantly declined and survival has improved, but the scary side of the equation is that younger men represent an increasing proportion of those diagnosed. The study was published in the June issue of Urology. Amgen researchers analyzed cancer epidemiological [...]

  • "DigniCap" May Prevent Hair Loss During Cancer Treatment

    Updated: 2010-12-20 15:39:00
    About Us Sponsored : by CTCA Cancer News Like Congress , Americans Split Over Health-Care Reform But even opponents back many provisions of the controversial law , Harris Interactive HealthDay poll finds Read full story Cancer News Categories Breast Cancer News Colorectal Cancer News Gynecologic Cancer News Hematological Cancer News Lung Cancer News Prostate Cancer News Pancreatic Cancer News Other Cancer News Message Board Cancers Bladder Cancer Bone Cancer Brain Cancer Breast Cancer Colon Cancer Esophageal Cancer Gynecological Cancers Kidney Cancer Leukemia Liver Cancer Lung Cancer Melanoma Pancreatic Cancer Prostate Cancer Stomach Cancer Testicular Cancer After Treatment Emotional Support Nutritional Concerns Side Effects Cancer Diagnosis Diagnostic Imaging Lab Tests Other Tests Cancer

  • Genes May Help PSA Test Accuracy

    Updated: 2010-12-17 17:00:00
    The accuracy of testing for prostate specific antigen (PSA) levels to assess risk of prostate cancer -- long assailed as far from perfect -- could be improved in the future by using genotyping, a study from Iceland suggested.

  • Controversial Breast Cancer Awareness Campaign Gets More Attention

    Updated: 2010-12-17 15:40:00
    About Us Sponsored : by CTCA Cancer News Like Congress , Americans Split Over Health-Care Reform But even opponents back many provisions of the controversial law , Harris Interactive HealthDay poll finds Read full story Cancer News Categories Breast Cancer News Colorectal Cancer News Gynecologic Cancer News Hematological Cancer News Lung Cancer News Prostate Cancer News Pancreatic Cancer News Other Cancer News Message Board Cancers Bladder Cancer Bone Cancer Brain Cancer Breast Cancer Colon Cancer Esophageal Cancer Gynecological Cancers Kidney Cancer Leukemia Liver Cancer Lung Cancer Melanoma Pancreatic Cancer Prostate Cancer Stomach Cancer Testicular Cancer After Treatment Emotional Support Nutritional Concerns Side Effects Cancer Diagnosis Diagnostic Imaging Lab Tests Other Tests Cancer

  • Professor Nic Jones appointed chief scientist of Cancer Research UK

    Updated: 2010-12-17 09:46:00
    A world-leading cancer researcher has been appointed as the next Chief Scientist of Cancer Research UK. Professor Nic Jones, currently Director of Cancer Research UK¿s Paterson Institute within the University of Manchester, takes up the role on 1 February 2011, succeeding Professor Sir David Lane.

  • ONE PERSON’S EXPERIENCE WITH PROVENGE

    Updated: 2010-12-16 21:22:58
    Malecare has an on-line support group for men with advanced prostate cancer; their loved ones and caretakers. Today, there was a post on the support group where one of the participants shared their recent experience with Provenge, including some very specific recommendations for anyone else thinking of having the treatment. You can join us by [...]

  • Study: Mood May Effect Breast Cancer Survival

    Updated: 2010-12-16 15:45:00
    : About Us Sponsored : by CTCA Cancer News Like Congress , Americans Split Over Health-Care Reform But even opponents back many provisions of the controversial law , Harris Interactive HealthDay poll finds Read full story Cancer News Categories Breast Cancer News Colorectal Cancer News Gynecologic Cancer News Hematological Cancer News Lung Cancer News Prostate Cancer News Pancreatic Cancer News Other Cancer News Message Board Cancers Bladder Cancer Bone Cancer Brain Cancer Breast Cancer Colon Cancer Esophageal Cancer Gynecological Cancers Kidney Cancer Leukemia Liver Cancer Lung Cancer Melanoma Pancreatic Cancer Prostate Cancer Stomach Cancer Testicular Cancer After Treatment Emotional Support Nutritional Concerns Side Effects Cancer Diagnosis Diagnostic Imaging Lab Tests Other Tests

  • The potential harms of "a non-invasive CT angiography test, just to 'reassure' the patient"

    Updated: 2010-12-16 14:41:35
    See this thoughtful blog post, "Why medical testing is never a simple decision," by Marya Zilberberg (@murzee on Twitter).

  • WSJ focuses on IMRT or intensity-modulated radiation therapy

    Updated: 2010-12-16 14:31:35
    I've been traveling in Europe, including giving a talk at the Salzburg Global Seminar on involving & informing patients in health care decisions. In that talk, I talked about promotion of a newer form of cancer radiation therapy called IMRT or intensity-modulated radiation therapy. So I want to point out that, while I've been away, the Wall Street Journal published an important piece on this very topic, under the headline, "A Device to Kill Cancer, Lift Revenue."

  • Genetic markers could improve prostate cancer test

    Updated: 2010-12-16 11:27:00
    Analysing small genetic variations (called SNPs) could provide a more accurate gauge for men's prostate cancer risk, report scientists at the company deCODE genetics.

  • Joint position statement issued to provide vitamin D clarity

    Updated: 2010-12-16 10:23:00
    Cancer Research UK has joined with the British Association of Dermatologists, Diabetes UK, the Multiple Sclerosis Society, the National Heart Forum, the National Osteoporosis Society and the Primary Care Dermatology Society to issue a joint position statement on vitamin D.

  • Study: Pomegranates Inhibit Prostate Cancer Cells Metastasizing

    Updated: 2010-12-15 21:57:00
    : About Us Sponsored : by CTCA Cancer News Like Congress , Americans Split Over Health-Care Reform But even opponents back many provisions of the controversial law , Harris Interactive HealthDay poll finds Read full story Cancer News Categories Breast Cancer News Colorectal Cancer News Gynecologic Cancer News Hematological Cancer News Lung Cancer News Prostate Cancer News Pancreatic Cancer News Other Cancer News Message Board Cancers Bladder Cancer Bone Cancer Brain Cancer Breast Cancer Colon Cancer Esophageal Cancer Gynecological Cancers Kidney Cancer Leukemia Liver Cancer Lung Cancer Melanoma Pancreatic Cancer Prostate Cancer Stomach Cancer Testicular Cancer After Treatment Emotional Support Nutritional Concerns Side Effects Cancer Diagnosis Diagnostic Imaging Lab Tests Other Tests

  • Join the One-in-Six Club

    Updated: 2010-12-15 21:46:49
    Consider making a donation toward the fight against prostate cancer by joining the 1-in-6 club today. Related posts:Women Against Prostate Cancer Support Group Launches Updated Website The Need for Support After Prostate Cancer

  • Zoledronic Acid Shows Improved Clinical Outcomes When Administered Prior to Bone Pain in Men with Advanced Prostate Cancer

    Updated: 2010-12-15 21:38:53
    According to the FDA approval label, zoledronic acid (Zometa) should be administered to men with advanced prostate cancer once they have failed one hormone therapy type, in other words, once the cancer has become castrate resistant. Researchers at the Centre Hospitalier de i’Université de Montréal, Hôpital Notre-Dame, Montréal, Quebec, Canada evaluated the effect of zoledronic [...]

  • Study finds cancer patients may face increased risk of food-borne illness listeria

    Updated: 2010-12-15 17:00:00
    People with cancer face an increased risk of developing the food-borne illness listeria, UK scientists have reported in the journal Emerging Infectious Diseases.

  • GPs to get powers to refer suspected cancer patients for tests

    Updated: 2010-12-14 15:38:00
    Patients with suspected cancer are to get faster access to diagnostic tests, under new government proposals set to be announced by Andrew Lansley today (December 14th).

  • Study: Daily Sunscreen Use May Prevent Melanoma

    Updated: 2010-12-14 15:33:00
    : Connect Search For Others Create Your Profile Participate Message Board Learn Cancer Atlas Cancer News Cancer Blog Cancer Information Weekly Cancer Newsletter Insurance Information Your Guide to Cancer Care Podcasts CF Thrive Magazine Recipes Empowering cancer patients to make informed . decisions Login or Join Now why join Dec 14 0 Study : Daily Sunscreen Use May Prevent Melanoma by : cancercompass According to a study recently published in the Journal of Clinical Oncology , sunscreen has been widely used to prevent squamous cell carcinoma , a type of nonmelanoma skin cancer . However , the study states that the effect of sunscreen used to prevent melanoma , the deadliest form of skin cancer , is highly controversial . Researchers observed over 1600 participants for 14 years . These

  • Denosumab delays the Spread of Prostate Cancer to the Bones, But it Doesn’t Extend Life!

    Updated: 2010-12-14 15:25:45
    Results from a recent clinical trial indicate that denosumab delayed the spread of prostate cancer metastases bones, however it did not prolong the lives of men. Despite these findings, Dr. Matthew R. Smith, the lead investigator in the trial and a consultant to Amgen, said the results were meaningful because no drug before had been [...]

  • Salzburg Global Seminar on involving & informing patients

    Updated: 2010-12-14 14:49:56
    e-patient Dave published a thoughtful blog entry about his involvement in a Salzburg Global Seminar at which I spoke earlier today. There is a fascinating group of people here from 19 nations. The seminar hosts have posted a bibliography page and a link to a video from journalist Ray Moynihan.

  • Capesaris™ (GTx-758) Phase II Proof of Concept Trial – A New On the Horizon Drug To Watch

    Updated: 2010-12-13 21:51:48
    GTx, Inc. this weekend presented results of the Capesaris™ (GTx-758) proof of concept pharmacokinetic-pharmacodynamic (PK/PD) clinical trial treating men with advanced prostate cancer, at the Annual Meeting of the Society of Urologic Oncology. Capesaris is a novel oral selective estrogen receptor alpha agonist which GTx is developing for first line treatment of advanced prostate cancer. [...]

  • Study: New Endometrial Cancer Screening Highly Detective, Yet Not Recommended for All

    Updated: 2010-12-13 15:28:00
    : , Connect Search For Others Create Your Profile Participate Message Board Learn Cancer Atlas Cancer News Cancer Blog Cancer Information Weekly Cancer Newsletter Insurance Information Your Guide to Cancer Care Podcasts CF Thrive Magazine Recipes Empowering cancer patients to make informed . decisions Login or Join Now why join Dec 13 0 Study : New Endometrial Cancer Screening Highly Detective , Yet Not Recommended for All by : cancercompass A cancer screening called transvaginal ultrasound may be able to detect early warning signs of endometrial cancer in postmenopausal women , according to a new study published in The Lancet . However , although there was more than an 80 percent detection accuracy with the transvaginal ultrasound , researchers are hesitant to immediately open the

  • Depression drug may relieve pain from breast cancer treatment

    Updated: 2010-12-13 13:18:59
    drug usually used to treat depression and anxiety disorder was effective at reducing joint and muscle pain linked to a breast cancer therapy, as per a research studyfrom the University of Michigan Comprehensive Cancer Center. The women in the study were taking aromatase inhibitors, a type of drug designed to block the production of estrogen, which fuels some breast cancers. About half of women taking these drugs experience aches and pains in their joints and muscles that cannot be adequately relieved by over-the-counter painkillers. Up to 20 percent of these women will stop taking an aromatase inhibitor because of this pain........

  • Expert analysis of HER2 tests

    Updated: 2010-12-13 13:18:59
    Results for testing breast tumors for HER2 (http://www.mayoclinic.com/health/breast-cancer/AN00495) proteins and genes is most often straightforward when one piece of tumor (a single tumor block) is analyzed. However, tumors can be diverse, and scientists at Mayo Clinic (http://www.mayoclinic.org/) observed that HER2 results can vary in up to 10 percent of patients when several tumor blocks are analyzed........

  • Ovarian cancer screening saves few lives

    Updated: 2010-12-13 13:15:43
    The best currently available screening tests can only slightly reduce ovary cancer deaths. That is the conclusion of new research published early online in Cancer, a peer-evaluated journal of the American Cancer Society. The results suggest that strategies other than screening, such as prevention and better therapys, will be needed to significantly lower the number of women who die from ovary cancer........

  • Discontinuation of breast cancer therapy

    Updated: 2010-12-13 13:15:43
    A higher prescription co-payment, particularly among older women, is linked to both early discontinuation and incomplete use of adjuvant aromatase inhibitor treatment, a life-saving treatment for women with hormone sensitive early stage breast cancer. Dawn L. Hershman, MD, associate professor of medicine and epidemiology and co-director of the Breast Cancer Program at the Herbert Irving Comprehensive Cancer Center at Columbia University, will be presenting detailed study results at The 33rd CTRC-AACR San Antonio Breast Cancer Symposium, a comprehensive scientific meeting covering the full spectrum of breast cancer research. Approximately 9,000 participants from more than 90 countries are expected to attend the symposium, Dec. 8-12, 2010........

  • Single gene essential for oestrogen response in breast cancer

    Updated: 2010-12-12 18:01:00
    Cancer Research UK scientists have discovered that a single gene controls the oestrogen-fuelled growth of breast cancer cells, according to research published in Nature Genetics today (Sunday).

  • Lifting Weights May Help Lymphedema

    Updated: 2010-12-10 15:52:00
    Connect Search For Others Create Your Profile Participate Message Board Learn Cancer Atlas Cancer News Cancer Blog Cancer Information Weekly Cancer Newsletter Insurance Information Your Guide to Cancer Care Podcasts CF Thrive Magazine Recipes Empowering cancer patients to make informed . decisions Login or Join Now why join Dec 10 0 Lifting Weights May Help Lymphedema by : cancercompass Breast cancer survivors may benefit from lifting weights after surgery , according to a new one year study recently published in the Journal of the American Medical . Association In breast cancer survivors at risk for lymphedema , a program of slowly progressive weight lifting compared with no exercise did not result in increased incidence of lymphedema , the study's conclusion states . Lymphedema is when

  • Cancer is biggest fear but 34 per cent put it down to fate

    Updated: 2010-12-08 00:01:00
    Cancer is the nation's number one fear but more than a third think getting the disease is down to fate and there is nothing they can do to avoid it - according to a Cancer Research UK survey out today (Wednesday).

  • Study supports use of radiotherapy in localised breast cancer (DCIS)

    Updated: 2010-12-08 00:01:00
    A new study in the Lancet Oncology medical journal has shown that women with ductal carcinoma in situ (DCIS), the most common type of non-invasive breast cancer, may benefit from radiotherapy after surgery.

  • Experts advise against mass screening programme for prostate cancer

    Updated: 2010-12-07 17:26:00
    The UK National Screening Committee (UK NSC) has advised against introducing a population screening programme for prostate cancer, after a review revealed that the harms involved with using the PSA test to screen for the disease would outweigh the benefits.

  • Personalized vaccine for lymphoma patients

    Updated: 2010-12-07 13:34:20
    A personalized vaccine is a powerful treatment to prevent recurrence among certain follicular lymphoma patients, as per the latest results of ongoing research led by the University of Pennsylvania School of Medicine. The new findings show that when these patients whose tumors are marked by a specific protein that appears to be present in up to half of people with this type of cancer -- receive a vaccine made from their own tumor cells, disease-free survival is improved by nearly two years, compared with patients who receive a placebo. Based on the new analysis, the team thinks they can explain why the results of prior trials of similar therapeutic cancer vaccines were not as strong as expected........

  • Daily low-dose aspirin 'reduces death rates for several cancers'

    Updated: 2010-12-07 00:01:00
    A new study in the Lancet medical journal adds to a growing body of evidence suggesting that a daily dose of aspirin can reduce the risk of dying from several types of cancer, with even low-dose aspirin appearing to be beneficial.

  • Long-Term Daily Aspirin Cuts Cancer Deaths

    Updated: 2010-12-06 22:30:00
    Daily aspirin use appeared to lower the risk of death from cancer in randomized trial participants, a meta-analysis found.

  • No Routine PSA Screen for U.K. Men

    Updated: 2010-12-06 22:29:21
    The United Kingdom's National Screening Committee has recommended against routine screening for prostate cancer risk with prostate specific antigen (PSA) testing.

  • Blog break until December 20

    Updated: 2010-12-04 14:38:30
    Santa must get away to his workshop for a while. He'll be back with new goodies soon. Meantime, despite Santa Schwitzer's blog break, we'll continue to post new story reviews in the left hand column of the home page of HealthNewsReview.org, thanks to ace substitute publisher Andrew Holtz and our terrific team of story reviewers.

  • Trial results show dramatically improved survival for relapsed childhood leukaemia

    Updated: 2010-12-04 00:01:00
    A new treatment increases survival to almost 70 per cent for children whose acute lymphoblastic leukaemia (ALL) returns, according to the results of a trial published online in the Lancet

Current Feed Items | Previous Months Items

Nov 2010 | Oct 2010 | Sep 2010 | Aug 2010 | Jul 2010 | Jun 2010